These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1795043)

  • 1. In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.
    Aime C; Cohen-Kaminsky S; Berrih-Aknin S
    J Clin Immunol; 1991 Sep; 11(5):268-78. PubMed ID: 1795043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells.
    Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H
    J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
    Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
    Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
    Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
    Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures.
    Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
    J Neurol Sci; 1981 May; 50(2):239-47. PubMed ID: 7014787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoid cells in the human thymus and thymoma revealed by three different immunohistochemical markers for striated muscle.
    Sato T; Tamaoki N
    Acta Pathol Jpn; 1989 Aug; 39(8):509-19. PubMed ID: 2816366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the malignant grade of thymoma by morphometric analysis.
    Nomori H; Horinouchi H; Kaseda S; Ishihara T; Torikata C
    Cancer; 1988 Mar; 61(5):982-8. PubMed ID: 3338061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ABH histo-blood group antigen expression in normal and myasthenic human thymus.
    Sarafian VS; Marinova TT
    APMIS; 2006 Oct; 114(10):669-74. PubMed ID: 17004969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
    Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
    J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
    Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
    J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.
    Hafer-Macko C; Pang M; Seilhamer JJ; Baum LG
    Glycoconj J; 1996 Aug; 13(4):591-7. PubMed ID: 8872116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoid cells and neuroendocrine markers in myasthenic thymuses.
    Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W
    Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.
    Bouchikh M; Zouaidia F; Benhaddou EHA; Mahassini N; Achir A; El Malki HO
    Rev Neurol (Paris); 2017 Jun; 173(6):388-395. PubMed ID: 28461027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathological study related to myoglobin in myasthenic and non-myasthenic thymuses.
    Koeda T
    Acta Pathol Jpn; 1986 Feb; 36(2):209-23. PubMed ID: 3518335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus.
    MacLennan CA; Beeson D; Willcox N; Vincent A; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():407-10. PubMed ID: 9668266
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative ultrastructural studies on three thymic lesions.
    Kay S
    Arch Pathol; 1970 Nov; 90(5):416-22. PubMed ID: 4319983
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.
    Fujii Y; Hayakawa M; Nakahara K
    J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between expression of Cat V and clinicopathologic character of myasthenia gravis in patients with thymoma].
    Wang Y; Huang Y; Luo DY; Yuan O; Gong RR; Qiu GD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):886-8. PubMed ID: 17236586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).
    Cornea R; Lazăr E; Dema A; Herman D
    Rom J Morphol Embryol; 2009; 50(4):729-31. PubMed ID: 19942974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.